Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold.
Journal: Journal of medicinal chemistry
Published: January 31, 2023
Discovery and Preclinical Profiling of GSK3839919, a Potent HIV-1 Allosteric Integrase Inhibitor.
Journal: ACS medicinal chemistry letters
Published: March 15, 2022
Scaffold modifications to the 4-(4,4-dimethylpiperidinyl) 2,6-dimethylpyridinyl class of HIV-1 allosteric integrase inhibitors.
Journal: Bioorganic & medicinal chemistry
Published: March 15, 2022
Design, Synthesis, and Preclinical Profiling of GSK3739936 (BMS-986180), an Allosteric Inhibitor of HIV-1 Integrase with Broad-Spectrum Activity toward 124/125 Polymorphs.
Journal: Journal of medicinal chemistry
Published: March 02, 2022
Design, synthesis and SAR study of novel C2-pyrazolopyrimidine amides and amide isosteres as allosteric integrase inhibitors.
Journal: Bioorganic & medicinal chemistry letters
Published: July 04, 2020
Design, synthesis and SAR study of bridged tricyclic pyrimidinone carboxamides as HIV-1 integrase inhibitors.
Journal: Bioorganic & medicinal chemistry
Published: February 06, 2020
Heterocycle amide isosteres: An approach to overcoming resistance for HIV-1 integrase strand transfer inhibitors.
Journal: Bioorganic & medicinal chemistry letters
Published: September 09, 2019
5,6,7,8-Tetrahydro-1,6-naphthyridine Derivatives as Potent HIV-1-Integrase-Allosteric-Site Inhibitors.
Journal: Journal of medicinal chemistry
Published: January 05, 2019
Synthesis and evaluation of C2-carbon-linked heterocyclic-5-hydroxy-6-oxo-dihydropyrimidine-4-carboxamides as HIV-1 integrase inhibitors.
Journal: Bioorganic & medicinal chemistry letters
Published: October 28, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026